cardiovascular-risk

Documents about cardiovascular-risk

• Physical Activity and Cardiovascular Risk#307369ClinicalTrials.gov
• Opioid tapering and risk of cardiovascular diseases among older adults: A case-crossover study#316746Scholar Commons
• Psychological Health, Polysocial Risk, and Cardiovascular Health Among Women of Reproductive Age.#320668NCBI PubMed Central
• Systolic Blood Pressure Reduction and Risk of Cardiovascular Disease and Mortality#383811CiNii
• Performance of Cardiovascular Polygenic Risk Scores in Carotid Stenosis Identification#398159bioRxiv / medRxiv
• Lipid Profile and Diabetes Mellitus in People With HIV#454100ClinicalTrials.gov
• Circadian Disruption And Cardiovascular Risk In Young Adults With Hypertension#467663ClinicalTrials.gov
• Emerging quantitative CCTA imaging biomarkers for cardiovascular risk stratification: a narrative review.#469165NCBI PubMed Central
• Monitoring and Modifying Atherosclerosis in Psoriasis Patients Study#805623ClinicalTrials.gov
• Knowledge of Cardiovascular Risk Factors in Chronic Kidney Disease Patients#805968ClinicalTrials.gov
• Supporting Post Myocardial Infarction (MI) Risk Modification Intervention Via Telemedicine Evaluation#806176ClinicalTrials.gov
• Multivariate Risk of CVD in Diverse Populations#806848ClinicalTrials.gov
• Tirzepatide vs Semaglutide in Individuals at Cardiovascular Risk But Without Diabetes.#840524ClinicalTrials.gov
• Risk Burden of Lipoprotein Metabolic Gene Haplotypes#863849ClinicalTrials.gov
• Cardiovascular Risk Factors and Severe COVID-19. A Nationwide Registry-based Case-Control Study#864881ClinicalTrials.gov
• Homocysteine and other markers of cardiovascular risk during a manic episode in patients with bipolar disorder#284711Lume 5.8
• Cardiac and Immune Cell Function in Preeclampsia#831906ClinicalTrials.gov
• Evaluation of Aging, Autonomic Nervous System Activity and Cardiovascular Events#835642ClinicalTrials.gov
• Emotion Regulation Training to Reduce Cardiovascular Disease Risk Among Depressed Young Adults in Southern Mississippi#838421ClinicalTrials.gov
• Psychological Impact of COVID-19 Quarantine and Worsening of Cardiovascular Risk in the French General Population#874393ClinicalTrials.gov
• Mitigation of Cardiovascular Disease Risks in Children With Extreme Obesity#901850ClinicalTrials.gov
• Association of triglyceride-glucose index (TyG) and a body shape index (ABSI) with cognitive decline and dementia risk#393164PLOS
• Role of Coronary CTA on Lipid Management and Risk Factors Control in an Asymptomatic Chinese Population#843412ClinicalTrials.gov
• The individual and combined effects of air pollution mixtures on the risk of cardiovascular diseases in patients with Cardiovascular-Kidney-Metabolic syndrome at stages 0-3.#320620NCBI PubMed Central
• Study of the Effects of Yerba Mate on Cardiometabolic Health#909459ClinicalTrials.gov
• Impact of Disclosing Coronary Artery Disease Polygenic Risk Score on Cardiovascular Health#841564ClinicalTrials.gov
• Afterload-Adjusted Strain Improves Risk Stratification Beyond Structural Remodeling in Mixed Aortic Valve Disease#138708bioRxiv / medRxiv
• Obstructive Sleep Apnea (OSA), Hypertension , β1 Subunit of Maxi-k+ Channel and Cardiovascular Risk#180256ClinicalTrials.gov
• Dietary circadian rhythms and cardiovascular disease risk in the prospective NutriNet-Santé cohort#218029HAL (France)
• Effect of Different Dosages of Dark Chocolate on Arterial Blood Pressure in Cardiovascular High-risk Patients#261384ClinicalTrials.gov
• Efficacy of Pioglitazone and Metformin on Cardiovascular Risk in Subjects With Insulin-Treated Type 2 Diabetes Mellitus.#300420ClinicalTrials.gov
• Improved Cardiovascular Risk Reduction to Enhance Rural Primary Care#314287ClinicalTrials.gov
• Efficacy of a Brief Intervention on Reduction of Systolic Blood Pressure#332835ClinicalTrials.gov
• Strength Training and Nutrition Development for African American Youth#349887ClinicalTrials.gov
• Deep learning for cardiovascular disease: a comprehensive review of detection and risk forecasting.#360626NCBI PubMed Central
• Distribution of Cardiovascular Disease Risk Factors Between Hypertensive and Normotensive Adults in Garissa County, Kenya#436398Kenyatta University Repository
• Supermarket and Web-Based Intervention Targeting Nutrition (SuperWIN) for Cardiovascular Risk Reduction#441986ClinicalTrials.gov
• Mapping the Evidence on Cardiovascular Disease Risk among Individuals Experiencing Disability: A Scoping Review.#631067NCBI PubMed Central
• Cleaner Air for Lower Cardiometabolic Risk#846283ClinicalTrials.gov
• Sickle Cell Disease and CardiovAscular Risk - Red Cell Exchange Trial (SCD-CARRE)#883901ClinicalTrials.gov
• MK0653C in High Cardiovascular Risk Patients With High Cholesterol (Switch Study)(MK-0653C-162)#894170ClinicalTrials.gov
• Imaging and Omics for Cardiovascular Risk During NASA Deep Space Missions#895760ClinicalTrials.gov
• Vascular Age: A narrative review of assessment methods, clinical applications, and future directions#5286Europe PMC
• Translation and validation of the Norwegian ABCD Risk Questionnaire to assess cardiovascular disease knowledge and risk perception prior to myocardial infarction.#281089NCBI PubMed Central
• Long-Term Association of Cardiovascular Risk Burden With Dementia Risk: The Role of Life-Course Confounders in an Analysis of Cumulative and Specific Factors.#326871NCBI PubMed Central
• Inclisiran for Subjects With ASCVD or ASCVD-Risk Equivalents and Elevated Low-density Lipoprotein Cholesterol#864388ClinicalTrials.gov
• Does Prophylactic Coronary Artery Revascularization for High Risk Patients Reduce Long-term Risk of Mortality#895650ClinicalTrials.gov
• Magnesium Variations and Cardiometabolic Risk in Patients With Antipsychotic Drugs#911175ClinicalTrials.gov
• Occurrence of coronary events in the absence of traditional risk factors: Understanding residual risk#137492HAL (France)
• Asociación del índice de triglicéridos-glucosa (índice TyG) y el riesgo cardiovascular en adultos de la ciudad de Tulcán, 2025#683325DIALNET OAI Articles